Neonatal respiratory failure

Current Opinion in Pediatrics

Volumn 14, Issue 3, 2002, Pages 315-321

  Rimensberger, Peter C ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; LUNG SURFACTANT; NITRIC OXIDE;

ANTIINFLAMMATORY ACTIVITY; ARTIFICIAL VENTILATION; CLINICAL FEATURE; CONTROLLED STUDY; DRUG POTENTIATION; HUMAN; LUNG DYSPLASIA; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; VENTILATOR;

ANTI-INFLAMMATORY AGENTS; BRONCHODILATOR AGENTS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; NITRIC OXIDE; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; VENTILATORS, MECHANICAL;

EID: 0036246235     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200206000-00006     Document Type: Review

References (110)

1. Deaths: Leading causes for 1999
2. Epidemiology of neonatal respiratory failure in the United States: Projections from California and New York
3. Epidemiology of neonatal acute respiratory disorders: A multicenter study on incidence and fatality rates of neonatal acute respiratory disorders according to gestational age, maternal age, pregnancy complications and type of delivery
4. Spectrum of respiratory distress in very low birthweight neonates
5. Outcomes of extremely low-birth-weight infants between 500 and 750 g
6. Survival, morbidity, and resource use of infants of 25 weeks' gestational age or less
7. Prophylactic corticosteroids for preterm birth
8. Surfactant replacement therapy: Economic impact
9. Inflammatory mechanisms in neonatal chronic lung disease
10. The role of inflammation in the development of chronic lung disease in neonates
11. Antenatal infection/inflammation and postnatal lung maturation and injury
12. New insights into the pathogenesis of pulmonary inflammation in preterm infants
13. Postnatal lung development and its impairment by glucocorticoids
14. Lung morphometry after repetitive antenatal glucocorticoid treatment in preterm sheep
15. Glucocorticoids and lung development in the fetus and preterm infant
16. Decreased alveolarization in baboon survivors with bronchopulmonary dysplasia
17. Neonatal chronic lung disease in extremely immature baboons
18. Chronic lung injury in preterm lambs: Disordered respiratory tract development
19. The new BPD: An arrest of lung development
20. Mechanical ventilation-induced pulmonary edema: Interaction with previous lung alterations
21. Evolving concepts in the pathogenesis of postinjury multiple organ failure
22. Immunopathology of a two-hit murine model of acid aspiration lung injury
23. Effects of mechanical ventilation on release of cytokines into systemic circulation in patients with normal pulmonary function
24. Early nasal continuous positive airway pressure treatment reduces the need for intubation in very low birth weight infants
25. Early application of CPAP in newborns with gestational age below 34 weeks lowers intubation rate and shortens oxygen therapy without altering mortality and morbidity
26. Nasal continuous positive airway pressure and outcomes of preterm infants
27. Cerebral palsy births in eastern Denmark, 1987-90: Implications for neonatal care
28. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome
29. Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants (Cochrane Review)
30. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation
31. Compliance of the respiratory system in newborn infants pre- and postsurfactant therapy
32. Static respiratory compliance in the newborn: III. Early changes after exogenous surfactant treatment
33. Pulmonary surfactant is altered during mechanical ventilation of isolated rat lung
34. Ventilator-induced injury: From barotrauma to biotrauma
35. Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome
36. Barotrauma is volutrauma, but which volume is the one responsible?
37. Tidal ventilation at low airway pressures can augment lung injury
38. Ventilator-induced lung injury: Lessons from experimental studies
39. Acute lung injury from mechanical ventilation at moderately high airway pressures
40. Tidal volume effects on surfactant treatment responses with the initiation of ventilation in preterm lambs
41. Lung volumes and pressure-volume relations of the respiratory system in small ventilated neonates with severe respiratory distress syndrome
42. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs
43. Lung recruitment at birth does not improve lung function in immature lambs receiving surfactant
44. Hypocarbia before surfactant therapy appears to increase bronchopulmonary dysplasia risk in infants with respiratory distress syndrome
45. The open lung during small tidal volume ventilation: Concepts of recruitment and "optimal" PEEP
46. Lung recruitment during small tidal volume ventilation allows minimal PEEP without augmenting lung injury
47. Best compliance during a decremental, but not incremental, positive end-expiratory pressure trial is related to open-lung positive end-expiratory pressure: A mathematical model of acute respiratory distress syndrome lungs
48. Recruitment and derecruitment during acute respiratory failure: A clinical study
49. Comparison of conventional and high-frequency ventilation: Oxygenation and lung pathology
50. Oxygenation during high-frequency ventilation compared with conventional mechanical ventilation in two models of lung injury
51. 2 and lung volume during high frequency oscillatory ventilation
52. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome
53. Sigh in acute respiratory distress syndrome
54. Pressure-Volume Curves. Searching for the grail or laying patients with adult respiratory distress syndrome on Procrustes' bed?
55. The pressure at the lower inflexion point has no relation to airway collapse in surfactant-treated premature lambs
56. The open lung concept: Pressure-controlled ventilation is as effective as high-frequency oscillatory ventilation in improving gas exchange and lung mechanics in surfactant-deficient animals
57. Lung recruitment and lung volume maintenance: A strategy for improving oxygenation and preventing lung injury during both conventional mechanical ventilation and high-frequency oscillation
58. Comparison of lung protection strategies using conventional and high-frequency oscillatory ventilation
59. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
60. Role of lung injury in the pathogenesis of hyaline membrane disease in premature baboons
61. Positive end-expiratory pressure preserves surfactant function in preterm lambs
62. High-frequency oscillatory ventilation: Effects on lung function, mechanics, and airway cytokines in the immature baboon model for neonatal chronic lung disease
63. Effects of ventilation with different positive end-expiratory pressures on cytokine expression in the preterm lamb lung
64. Positive pressure ventilation using the open lung concept: Inflammation and protein infiltration in newborn piglets
65. Alveolar recruitment promotes homogeneous surfactant distribution in a piglet model of lung injury
66. Optimizing alveolar expansion prolongs the effectiveness of exogenous surfactant therapy in the adult rabbit
67. Independent and combined effects of inhaled nitric oxide, liquid perfluorochemical, and high-frequency oscillatory ventilation in premature lambs with respiratory distress syndrome
68. High-frequency oscillatory ventilation and partial liquid ventilation after acute lung injury in premature lambs with respiratory distress syndrome
69. Effects of prolonged partial liquid ventilation, high frequency ventilation and conventional ventilation on gas exchange and lung pathology in newborn surfactant-depleted piglets
70. Surfactant and acute lung injury
71. A comparison of surfactant delivery with conventional mechanical ventilation and partial liquid ventilation in meconium aspiration injury
72. Concealed air leak associated with large tidal volumes in partial liquid ventilation
73. Hemodynamic effects of positive end-expiratory pressure during partial liquid ventilation in newborn lambs
74. Effect of positive end expiratory pressure on functional residual capacity and compliance in surfactant-treated preterm infants
75. Optimum end-expiratory airway pressure in patients with acute pulmonary failure
76. First intention high-frequency oscillation (HFO) with early lung volume optimization improves pulmonary outcome in preterm infants with respiratory distress syndrome
77. High-frequency oscillatory ventilation in neonatal RDS: Initial volume optimization and respiratory mechanics
78. Reduction of oscillatory pressure along the endotracheal tube is indicative for maximal respiratory compliance during high-frequency oscillatory ventilation: A mathematical model study
79. Lung volume recruitment in lambs during high-frequency oscillatory ventilation using respiratory inductive plethysmography
80. Non-invasive assessment of shunt and ventilation/perfusion ratio in neonates with pulmonary failure
81. High frequency oscillatory ventilation versus intermittent mandatory ventilation: Early hemodynamic effects in the premature baboon with hyaline membrane disease
82. Prognosis with preoperative pulmonary function and lung volume assessment in infants with congenital diaphragmatic hernia
83. Non-invasive radiation-free monitoring of regional lung ventilation in critically ill infants
84. High-frequency oscillatory ventilation compared with conventional ventilation in the treatment of respiratory failure in preterm infants
85. Rescue high frequency oscillatory ventilation vs conventional ventilation for infants with severe pulmonary dysfunction born at or near term (Cochrane Review)
86. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants (Cochrane Review)
87. Prospective randomized multicenter comparison of high-frequency oscillatory ventilation and conventional ventilation in preterm infants of less than 30 weeks with respiratory distress syndrome
88. Multicenter trial of high frequency ventilation
89. Early high-frequency oscillatory ventilation versus synchronized intermittent mandatory ventilation in very low birth weight infants: A pilot study of two ventilation protocols
90. Effects of hypocarbia on the development of cystic periventricular leukomalacia in premature infants treated with high-frequency jet ventilation
91. Hypocarbia in preterm infants with periventricular leukomalacia: The relation between hypocarbia and mechanical ventilation
92. Hypocarbia during the first 24 postnatal hours and white matter echolucencies in newborns < or = 28 weeks gestation
93. Elective high frequency oscillaratory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants
94. Newer modes of mechanical ventilation for the neonate
95. International randomised controlled trial of patient triggered ventilation in neonatal respiratory distress syndrome
96. Synchronized mechanical ventilation for respiratory support in newborn infants
97. Feasibility of tidal volume-guided ventilation in new-born infants: A randomized, crossover trial using the volume guarantee modality
98. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy
99. Impaired cerebral cortical gray matter growth after treatment with dexamethasone for neonatal chronic lung disease
100. Early postnatal dexamethasone therapy for the prevention of chronic lung disease
101. The effect of postnatal steroids on growth and development
102. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants (Cochrane Review)
103. Inhaled nitric oxide in neonates with persistent pulmonary hypertension
104. Inhaled nitric oxide for respiratory failure in preterm infants (Cochrane Review)
105. Nitric oxide for respiratory failure in infants born at or near term (Cochrane Review)
106. New trends in extracorporeal membrane oxygenation in newborn pulmonary diseases
107. Inhaled nitric oxide in term and near-term infants: Neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS)
108. Surfactant in respiratory distress syndrome and lung injury
109. Biology of surfactant